tag:blogger.com,1999:blog-8550428.post5239035301926557914..comments2024-03-10T05:12:12.373-04:00Comments on Pharma Marketing Blog: FDA's Bad Ad Program is "Phoniest Thing Ever!"Vladhttp://www.blogger.com/profile/04114063498108633047noreply@blogger.comBlogger3125tag:blogger.com,1999:blog-8550428.post-88898350250156015732011-04-28T14:25:46.192-04:002011-04-28T14:25:46.192-04:00You mean it should have been more "balanced?&...You mean it should have been more "balanced?"PharmaGuyhttps://www.blogger.com/profile/10211557578124130640noreply@blogger.comtag:blogger.com,1999:blog-8550428.post-10099433858472981142011-04-28T14:06:25.799-04:002011-04-28T14:06:25.799-04:00The BadAd webinar was unremarkable, except for exc...The BadAd webinar was unremarkable, except for excessive self-promotion. Anyone who had access to the program would surely be sophisticated enough to know DDMAC and its designs without having to listen to that insipid introduction. The program could have benefitted from targeting to a higher education level and the FDA.gov advertisment should carry a boxed warning about the vapid and patronizing content.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-8550428.post-41967606405695882132011-04-25T11:29:10.808-04:002011-04-25T11:29:10.808-04:00Actually, the letter to Hill isn't the only on...Actually, the letter to Hill isn't the only one letter to come out of the Bad Ad Program. Sam Waksal's (think "ImClone") new company Kadmon got a letter that was posted on FDA's website on 4/19/2011. An interesting read. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm251030.htmAnonymousnoreply@blogger.com